Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, W.
(Chest. 1974;65:3-8.)
© 1974 American College of Chest Physicians

Tumor Doubling Time and Survival of Men with Bronchogenic Carcinoma

William Weiss M.D.1

1 Professor of Medicine, Hahnemann Medical College and Clinical Director, Pulmonary Disease Service, Philadelphia General Hospital

The relationship between tumor volume doubling time and survival was studied in 28 patients with histologically confirmed bronchogenic carcinoma with the following characteristics: the cancers presented radiographically as circumscribed peripheral nodules first observed at a diameter of 0.6 to 1.4 cm, and follow-up was maintained until death or for at least 8.5 years from the time the tumor was 1.0 cm in diameter. Among eight patients whose cancers were not resected, survival was longer in the four treated with radiation than in the four who were not. Among 20 patients whose cancers were resected, 18 who died showed a fair correlation between tumor doubling time and survival; the other two patients were still alive 116 and 143 months after the tumors were 1 cm in diameter, presumably cured. These observations indicate that tumor growth rate is an important factor in the prognosis of patients with bronchogenic carcinoma.

Submitted on April 11, 1974
Accepted on June 11, 1974




This article has been cited by other articles:


Home page
RadiologyHome page
S. G. Jennings, H. T. Winer-Muram, M. Tann, J. Ying, and I. Dowdeswell
Distribution of Stage I Lung Cancer Growth Rates Determined with Serial Volumetric CT Measurements
Radiology, November 1, 2006; 241(2): 554 - 563.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram
The solitary pulmonary nodule.
Radiology, April 1, 2006; 239(1): 34 - 49.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. J. Kostis, D. F. Yankelevitz, A. P. Reeves, S. C. Fluture, and C. I. Henschke
Small Pulmonary Nodules: Reproducibility of Three-dimensional Volumetric Measurement and Estimation of Time to Follow-up CT
Radiology, May 1, 2004; 231(2): 446 - 452.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram, S. G. Jennings, R. D. Tarver, A. M. Aisen, M. Tann, D. J. Conces, and C. A. Meyer
Volumetric Growth Rate of Stage I Lung Cancer prior to Treatment: Serial CT Scanning
Radiology, June 1, 2002; 223(3): 798 - 805.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Chest Physicians.